Literature DB >> 30712990

Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance.

Jiajie Wei1, Rigel J Kishton2, Matthew Angel3, Crystal S Conn4, Nicole Dalla-Venezia5, Virginie Marcel5, Anne Vincent5, Frédéric Catez5, Sabrina Ferré6, Lilia Ayadi7, Virginie Marchand7, Devin Dersh3, James S Gibbs3, Ivaylo P Ivanov8, Nathan Fridlyand9, Yohann Couté6, Jean-Jacques Diaz5, Shu-Bing Qian4, Louis M Staudt10, Nicholas P Restifo11, Jonathan W Yewdell12.   

Abstract

The MHC class I antigen presentation system enables T cell immunosurveillance of cancers and viruses. A substantial fraction of the immunopeptidome derives from rapidly degraded nascent polypeptides (DRiPs). By knocking down each of the 80 ribosomal proteins, we identified proteins that modulate peptide generation without altering source protein expression. We show that 60S ribosomal proteins L6 (RPL6) and RPL28, which are adjacent on the ribosome, play opposite roles in generating an influenza A virus-encoded peptide. Depleting RPL6 decreases ubiquitin-dependent peptide presentation, whereas depleting RPL28 increases ubiquitin-dependent and -independent peptide presentation. 40S ribosomal protein S28 (RPS28) knockdown increases total peptide supply in uninfected cells by increasing DRiP synthesis from non-canonical translation of "untranslated" regions and non-AUG start codons and sensitizes tumor cells for T cell targeting. Our findings raise the possibility of modulating immunosurveillance by pharmaceutical targeting ribosomes. Published by Elsevier Inc.

Entities:  

Keywords:  MHC-I antigen presentation; immunosurveillance; ribosomal protein

Mesh:

Substances:

Year:  2019        PMID: 30712990      PMCID: PMC6697054          DOI: 10.1016/j.molcel.2018.12.020

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  64 in total

1.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.

Authors:  U Schubert; L C Antón; J Gibbs; C C Norbury; J W Yewdell; J R Bennink
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.

Authors:  C J Luckey; J A Marto; M Partridge; E Hall; F M White; J D Lippolis; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

3.  HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation.

Authors:  R A Henderson; H Michel; K Sakaguchi; J Shabanowitz; E Appella; D F Hunt; V H Engelhard
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

4.  The DRiP hypothesis decennial: support, controversy, refinement and extension.

Authors:  Jonathan W Yewdell; Christopher V Nicchitta
Journal:  Trends Immunol       Date:  2006-07-11       Impact factor: 16.687

5.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.

Authors:  Jürgen Cox; Matthias Mann
Journal:  Nat Biotechnol       Date:  2008-11-30       Impact factor: 54.908

6.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

7.  Attenuation of equine influenza viruses through truncations of the NS1 protein.

Authors:  Michelle Quinlivan; Dmitriy Zamarin; Adolfo García-Sastre; Ann Cullinane; Thomas Chambers; Peter Palese
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Viral alteration of cellular translational machinery increases defective ribosomal products.

Authors:  Peter Berglund; Diana Finzi; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

9.  Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines.

Authors:  David C Tscharke; Gunasegaran Karupiah; Jie Zhou; Tara Palmore; Kari R Irvine; S M Mansour Haeryfar; Shanicka Williams; John Sidney; Alessandro Sette; Jack R Bennink; Jonathan W Yewdell
Journal:  J Exp Med       Date:  2004-12-28       Impact factor: 14.307

10.  RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.

Authors:  F Esquivel; J Yewdell; J Bennink
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  28 in total

1.  Single-cell entropy network detects the activity of immune cells based on ribosomal protein genes.

Authors:  Qiqi Jin; Chunman Zuo; Haoyue Cui; Lin Li; Yiwen Yang; Hao Dai; Luonan Chen
Journal:  Comput Struct Biotechnol J       Date:  2022-06-30       Impact factor: 6.155

2.  Deficiency of ribosomal proteins reshapes the transcriptional and translational landscape in human cells.

Authors:  Yizhao Luan; Nan Tang; Jiaqi Yang; Shuting Liu; Chichi Cheng; Yan Wang; Congying Chen; Ya-Nan Guo; Hongwei Wang; Wenxue Zhao; Qian Zhao; Wei Li; Mengqing Xiang; Rong Ju; Zhi Xie
Journal:  Nucleic Acids Res       Date:  2022-07-08       Impact factor: 19.160

Review 3.  A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion.

Authors:  Devin Dersh; Jaroslav Hollý; Jonathan W Yewdell
Journal:  Nat Rev Immunol       Date:  2020-08-20       Impact factor: 53.106

Review 4.  From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.

Authors:  John F Atkins; Kate M O'Connor; Pramod R Bhatt; Gary Loughran
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.048

Review 5.  Beneficial autoimmunity improves cancer prognosis.

Authors:  Laurence Zitvogel; Claude Perreault; Olivera J Finn; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2021-05-11       Impact factor: 65.011

Review 6.  Non-AUG translation initiation in mammals.

Authors:  Dmitry E Andreev; Gary Loughran; Alla D Fedorova; Maria S Mikhaylova; Ivan N Shatsky; Pavel V Baranov
Journal:  Genome Biol       Date:  2022-05-09       Impact factor: 17.906

7.  Hybrid Gene Origination Creates Human-Virus Chimeric Proteins during Infection.

Authors:  Jessica Sook Yuin Ho; Matthew Angel; Yixuan Ma; Elizabeth Sloan; Guojun Wang; Carles Martinez-Romero; Marta Alenquer; Vladimir Roudko; Liliane Chung; Simin Zheng; Max Chang; Yesai Fstkchyan; Sara Clohisey; Adam M Dinan; James Gibbs; Robert Gifford; Rong Shen; Quan Gu; Nerea Irigoyen; Laura Campisi; Cheng Huang; Nan Zhao; Joshua D Jones; Ingeborg van Knippenberg; Zeyu Zhu; Natasha Moshkina; Léa Meyer; Justine Noel; Zuleyma Peralta; Veronica Rezelj; Robyn Kaake; Brad Rosenberg; Bo Wang; Jiajie Wei; Slobodan Paessler; Helen M Wise; Jeffrey Johnson; Alessandro Vannini; Maria João Amorim; J Kenneth Baillie; Emily R Miraldi; Christopher Benner; Ian Brierley; Paul Digard; Marta Łuksza; Andrew E Firth; Nevan Krogan; Benjamin D Greenbaum; Megan K MacLeod; Harm van Bakel; Adolfo Garcìa-Sastre; Jonathan W Yewdell; Edward Hutchinson; Ivan Marazzi
Journal:  Cell       Date:  2020-06-18       Impact factor: 41.582

8.  The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy.

Authors:  Marie-Pierre Hardy; Krystel Vincent; Claude Perreault
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

9.  Most non-canonical proteins uniquely populate the proteome or immunopeptidome.

Authors:  Maria Virginia Ruiz Cuevas; Marie-Pierre Hardy; Jaroslav Hollý; Éric Bonneil; Chantal Durette; Mathieu Courcelles; Joël Lanoix; Caroline Côté; Louis M Staudt; Sébastien Lemieux; Pierre Thibault; Claude Perreault; Jonathan W Yewdell
Journal:  Cell Rep       Date:  2021-03-09       Impact factor: 9.423

Review 10.  The Origin and Immune Recognition of Tumor-Specific Antigens.

Authors:  Anca Apavaloaei; Marie-Pierre Hardy; Pierre Thibault; Claude Perreault
Journal:  Cancers (Basel)       Date:  2020-09-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.